Prior studies showed brain microvasculature abnormalities, including decreased vessel diameter, obstructed blood flow61, and BBB breakdown22 in mouse models of tauopathy but whether pathogenic tau has a role in brain microvascular dysfunction of AD remains unclear. This evidence concerns the gene MAPT and Alzheimer disease.